No Data
Guangdong Transtek Medical Electronics Co., Ltd's (SZSE:300562) Market Cap Rose CN¥606m Last Week; Individual Investors Who Hold 54% Profited and so Did Insiders
guangdong transtek medical electronics (300562.SZ): The extension of the medical instruments production license applied by Richco Healthcare has been approved.
Gelonghui, November 18 - Guangdong Transtek Medical Electronics (300562.SZ) announced that its holding subsidiary, Shenzhen Ruikang Hongye Technology Development Co., Ltd. (hereinafter referred to as "Ruikang Hongye" or "subsidiary"), recently received the "Medical Instruments Production License" issued by the Guangdong Provincial Pharmaceutical Supervision Administration (License No.: Yue Shi Yao Jian Xie Sheng Chan Xu 20142566). It has been learned that the application for the continuation of the medical instruments production license by Ruikang Hongye has been approved.
Lexin Healthcare: Report for the third quarter of 2024
Guangdong Transtek Medical Electronics (300562.SZ): Lepu OTC hearing aids have achieved innovative functions such as adaptive hearing tests, automatic adaptation, and user hearing data tracking.
格隆汇October 16th | guangdong transtek medical electronics (300562.SZ) stated in the investor relations that the company focuses on the digital chronic disease management sector, deeply integrating health IoT, big data, AI, and medical services, accelerating the commercial application of cardiovascular digital chronic disease services. Currently, the main directions of AI technology application are: (1) Applied to medical diagnosis: mainly in the remote electrocardiogram service sector - dynamic electrocardiogram diagnosis (self-developed AI algorithm), innovative wearable electrocardiographic devices as carriers, leading AI algorithms as pioneers, focusing on solving critical diseases such as heart disease, stroke, etc.
Guangdong Transtek Medical Electronics (300562.SZ): has professional medical-grade devices such as smart ECG garments, real-time dynamic ECG (4G Holter), dynamic blood pressure, and a platform for cardiac monitoring services.
Geruihu reports on October 16th that Guangdong Transtek Medical Electronics (300562.SZ) stated in investor relations that the company focuses on the digital chronic disease management sector. The remote dynamic electrocardiogram sector is one of the company's global strategy sectors. Currently, the company owns professional medical-grade equipment and electrocardiographic monitoring service platforms such as smart electrocardiogram garments, real-time dynamic electrocardiograms (4G Holter), dynamic electrocardiograms, electrocardiogram networks, smart heart patches, and dynamic blood pressure. The core product of this sector, the 'Twelve-lead Smart Electrocardiogram Garment' (iSENSE series), has officially obtained the Guangdong Province Food and Drug Administration's 'Class II Medical Device Registration Certificate', while the heart...
Guangdong Transtek Medical Electronics (300562.SZ): Repurchase completed, already repurchased 1.11% of shares.
Guangdong Transtek Medical Electronics (300562.SZ) announced on October 11 that, as of October 9, 2024, the company's share repurchase plan has been fully implemented. As of October 9, 2024, the company has repurchased a total of 2.4122 million shares through a centralized competitive bidding method using a repurchase special securities account, accounting for 1.11% of the company's current total share capital (which is 217,466,188 shares). From the initial repurchase to October 9, 2024, the highest fill price for the company's share repurchase was 13.24 yuan per share, and the lowest fill price was 6.05 yuan per share.
It's Down 30% But Guangdong Transtek Medical Electronics Co., Ltd (SZSE:300562) Could Be Riskier Than It Looks
